In fact, it has been shown that VEGFR-2 inhibition enhances the cytotoxic effect of EGFR inhibitors, whereas, VEGFR-2 activation results in accelerated tumour growth independent of EGFR signalling, thereby facilitating the emergence of resistance to EGFR inhibitors.33 Here, EGFR is linked to neoplasm.